PART I . GENERAL ORGANIZATION AND BUSINESS Bioxytran, Inc. (we, us, or the Company) is a clinical stage pharmaceutical company focused on the development, manufacture and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen to tissues. Hypoxia needs to be addressed quickly, otherwise it results in necrosis, which is the death of cells comprising body tissue. Necrosis cannot be reversed. Our lead drug candidate, code named BXT-25, is an oxygen-ca...
Q2 FY2026 — expected 2026-08-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-03 | 2024-12-31 | 0001641172-25-002614 | EDGAR | 52K words |
| 2024-03-22 | 2023-12-31 | 0001493152-24-011014 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010104 | EDGAR | — |
| 2022-04-11 | 2021-12-31 | 0001539497-22-000793 | EDGAR | — |
| 2021-04-09 | 2020-12-31 | 0001785982-21-000076 | EDGAR | — |
| 2020-03-18 | 2019-12-31 | 0001213900-20-006766 | EDGAR | — |
| 2019-03-13 | 2018-12-31 | 0001213900-19-004006 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001213900-18-003761 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001213900-17-003123 | EDGAR | — |
| 2016-07-22 | 2015-12-31 | 0001213900-16-015178 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001493152-25-023399 | EDGAR | 24K words |
| 2025-08-11 | 2025-06-30 | 0001493152-25-011797 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010822 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0001493152-24-042763 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032356 | EDGAR | — |
| 2024-04-19 | 2024-03-31 | 0001493152-24-015358 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001493152-23-039202 | EDGAR | — |
| 2023-07-31 | 2023-06-30 | 0001493152-23-026050 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016483 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031402 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022572 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001539497-22-001047 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001493152-26-036977 | EDGAR | — |
| 2026-03-20 | 0001493152-26-011755 | EDGAR | 1K words |
| 2026-03-13 | 0001493152-26-010045 | EDGAR | — |
| 2026-03-02 | 0001493152-26-008475 | EDGAR | — |
| 2026-02-17 | 0001493152-26-006891 | EDGAR | — |
| 2026-02-11 | 0001493152-26-006081 | EDGAR | — |
| 2026-01-05 | 0001493152-26-000418 | EDGAR | — |
| 2025-12-15 | 0001493152-25-027639 | EDGAR | — |
| 2025-01-22 | 0001493152-25-003136 | EDGAR | — |
| 2025-01-13 | 0001493152-25-001891 | EDGAR | — |
202 total filings indexed. 170 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001445815 |
| Ticker | BIXT |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BIXT (~200 tokens, structured JSON with cryptographic provenance)